Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
Edoardo Spina, María Antonietta Barbieri, Giuseppe Cicala, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 439-439
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 183
Escaping the Long Shadow Cast by Agranulocytosis
José de León, Manuel Arrojo, Hélène Verdoux, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 239-245
Closed Access | Times Cited: 20
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition
Georgios Schoretsanitis, A. Elif Anıl Yağcıoğlu, Can‐Jun Ruan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 302-307
Closed Access | Times Cited: 18
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
Can‐Jun Ruan, I. Cánovas Olmos, Carina Ricciardi, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 15
Gender Differences in Potentially Inappropriate Medication Use among Older Adults
Monira Alwhaibi, Bander Balkhi
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 869-869
Open Access | Times Cited: 14
Question
José de León
Journal of Clinical Psychopharmacology (2024) Vol. 44, Iss. 2, pp. 201-203
Closed Access | Times Cited: 5
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 4
A case of invasive pulmonary aspergillosis associated with clozapine‐induced agranulocytosis
Akiyoshi Yokode, Masaki Fujiwara, Toshiki Terao, et al.
Psychiatry and Clinical Neurosciences Reports (2025) Vol. 4, Iss. 1
Open Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Incidence and risk profiles for pneumonia in patients with schizophrenia receiving home-care case management intervention in Taiwan
Yuting Liu, Wen‐Ying Chen, Po‐Yu Chen, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Closed Access
Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies—A Narrative Review
Tudor-Florentin Capatina, Anamaria Oatu, Casandra Babasan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4285-4285
Open Access
Therapeutic drug monitoring of clozapine in human serum by high-throughput paper spray mass spectrometry
Armin Saatchi, Taelor M. Zarkovic, Scott A. Borden, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2024) Vol. 32, pp. 41-46
Open Access | Times Cited: 3
Severe mental illness and infectious disease mortality: a systematic review and meta-analysis
Amy Ronaldson, Isabelle Nascimento Santana, Sophie Carlisle, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102867-102867
Closed Access | Times Cited: 2
Identification of clinical phenotypes in schizophrenia: the role of lurasidone
Marco Andrea Riva, Umberto Albert, Sergio De Filippis, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 13
Precision psychiatry: The complexity of personalizing antipsychotic dosing
José de León
European Neuropsychopharmacology (2022) Vol. 58, pp. 80-85
Closed Access | Times Cited: 9
Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction
Reham Z. Hamza, Fatima S. Alaryani, Fatma A. Omara, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 6, pp. 2529-2541
Open Access | Times Cited: 9
Potentially inappropriate prescriptions of antibiotics in geriatric psychiatry—a retrospective cohort study
Tabea Pfister, Sebastian Schröder, Johannes Heck, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 1
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
Marianna Cocco, Carla Carnovale, Emilio Clementi, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 5-6, pp. 441-453
Closed Access | Times Cited: 1
Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians
Sorina Hîncu, Miruna-Maria Apetroaei, G. Stefan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1137-1137
Open Access | Times Cited: 1
Pharmacokinetic drug interactions with oral haloperidol in adults: dose correction factors from a combined weighted analysis
Ian R. McGrane, Edoardo Spina, Christoph Hiemke, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 2, pp. 135-149
Closed Access | Times Cited: 7
Comorbidities and the right dose: antipsychotics
Nicolas Simon, Romain Torrents, Jean‐Michel Azorin
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 7-8, pp. 507-518
Closed Access | Times Cited: 6
A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring
Fei Jia, Yannan Zang, Can‐Jun Ruan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 308-311
Closed Access | Times Cited: 3
An Atypical Case of Neuroleptic Malignant Syndrome Associated With Ciprofloxacin and Quetiapine
Muhammad U Rohail, Ayub Khan, Rhani M Pflaum, et al.
Cureus (2023)
Open Access | Times Cited: 2
Drug–Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study
Caterina Trevisan, Andrea Cignarella, Andrea Grandieri, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 2, pp. 42-42
Open Access
Part II: Interactive case—Clinical pearls of clozapine
Jonathan G. Leung
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2023) Vol. 6, Iss. 3, pp. 312-318
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top